Jason N. Butler
Stock Analyst at Citizens
(3.63)
# 825
Out of 5,120 analysts
11
Total ratings
72.73%
Success rate
4.13%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jason N. Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHV Achieve Life Sciences | Initiates: Market Outperform | $19 | $4.30 | +341.86% | 1 | Nov 25, 2025 | |
| RAPP Rapport Therapeutics | Maintains: Market Outperform | $77 → $80 | $27.83 | +187.46% | 1 | Nov 7, 2025 | |
| WULF TeraWulf | Maintains: Market Outperform | $18 → $22 | $13.44 | +63.69% | 1 | Oct 29, 2025 | |
| RZLT Rezolute | Maintains: Market Outperform | $9 → $17 | $3.24 | +424.69% | 1 | Oct 29, 2025 | |
| ABVX ABIVAX Société Anonyme | Maintains: Market Outperform | $95 → $114 | $111.46 | +2.28% | 1 | Sep 25, 2025 | |
| CRMD CorMedix | Reiterates: Market Outperform | $22 | $8.17 | +169.28% | 1 | Sep 9, 2025 | |
| CYTK Cytokinetics | Reiterates: Market Outperform | $78 | $65.16 | +19.71% | 1 | Sep 2, 2025 | |
| PGEN Precigen | Maintains: Market Outperform | $6 → $8 | $4.83 | +65.63% | 1 | Aug 19, 2025 | |
| ZVRA Zevra Therapeutics | Maintains: Market Outperform | $19 → $18 | $9.36 | +92.31% | 1 | Aug 13, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Market Outperform | $30 → $35 | $26.13 | +33.95% | 1 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $91 → $78 | $74.45 | +4.77% | 1 | Aug 6, 2025 |
Achieve Life Sciences
Nov 25, 2025
Initiates: Market Outperform
Price Target: $19
Current: $4.30
Upside: +341.86%
Rapport Therapeutics
Nov 7, 2025
Maintains: Market Outperform
Price Target: $77 → $80
Current: $27.83
Upside: +187.46%
TeraWulf
Oct 29, 2025
Maintains: Market Outperform
Price Target: $18 → $22
Current: $13.44
Upside: +63.69%
Rezolute
Oct 29, 2025
Maintains: Market Outperform
Price Target: $9 → $17
Current: $3.24
Upside: +424.69%
ABIVAX Société Anonyme
Sep 25, 2025
Maintains: Market Outperform
Price Target: $95 → $114
Current: $111.46
Upside: +2.28%
CorMedix
Sep 9, 2025
Reiterates: Market Outperform
Price Target: $22
Current: $8.17
Upside: +169.28%
Cytokinetics
Sep 2, 2025
Reiterates: Market Outperform
Price Target: $78
Current: $65.16
Upside: +19.71%
Precigen
Aug 19, 2025
Maintains: Market Outperform
Price Target: $6 → $8
Current: $4.83
Upside: +65.63%
Zevra Therapeutics
Aug 13, 2025
Maintains: Market Outperform
Price Target: $19 → $18
Current: $9.36
Upside: +92.31%
ACADIA Pharmaceuticals
Aug 7, 2025
Maintains: Market Outperform
Price Target: $30 → $35
Current: $26.13
Upside: +33.95%
Aug 6, 2025
Maintains: Market Outperform
Price Target: $91 → $78
Current: $74.45
Upside: +4.77%